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ABSTRACT 
Pretreatment  of human platelets  with  the  metabolic inhibitors  rotenone and  2- 
deoxyglucose, before  French press  homogenization, has  led  to  the  isolation  of 
dense storage granules in an overall yield of about 20%. The concentrations of 
serotonin,  ATP and ADP were estimated in  the  dense  granules.  Serotonin was 
40-60-fold enriched in the dense granules compared to the platelet homogenate. 
Stored ATP and ADP were also 40-fold enriched in the dense granules compared 
to  the  estimated  storage  nucleotide  pool in  intact  platelets.  The  ATP to  ADP 
ratio in the isolated dense granules was 0.68-0.70, the same as the ratio of the 
secreted  ATP and  ADP.  In platelets  prelabeled  with  [SH]adenine,  the  specific 
radioactivities  of the  ATP and  ADP in  the  isolated  dense  granules  and  of the 
secreted  ATP  and  ADP were  both  negligible,  whereas  the  estimated  specific 
radioactivity  of the  metabolically  active  ATP  and  ADP was  2,000  cpm/nmol. 
These results confirm that the ATP and ADP in the isolated dense granules are 
the same as the secreted ATP and ADP in terms of metabolic inactivity and their 
ATP to ADP ratios. 
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Blood platelets  contain  secretory  granules  which 
disappear  when the cells are treated with appro- 
priate  stimuli  such  as  ADP  or  thrombin  (for 
review,  see  reference  13).  At least  two types  of 
such granules are known to be present in platelets 
as shown by the selective release caused by certain 
of the inducing agents. ADP, for example, induces 
the release of serotonin, ATP, ADP, and calcium 
but  not  of lysosomal  enzymes.  It  is  considered 
that the former compounds are stored together in 
one  type of granule  which  is  different  from the 
granules  that  contain  lysosomal  enzymes  which 
can  be  released  by thrombin.  Radioautographic 
techniques  have shown that serotonin is stored in 
the highly electron-dense  granules  (9), while elec- 
tron microprobe  X-ray spectroscopy  revealed  the 
presence of both calcium and phosphorus in them 
(21, 29). Further evidence for the common stor- 
age of these  compounds in the  dense  granules is 
that  platelets  which lack  dense  granules  contain 
very  much less  ATP,  ADP, serotonin,  and cal- 
cium than normal platelets  (12, 18, 19). 
Dense granules isolated by subceUular fraction- 
ation  from the platelets  of guinea  pig, rabbit  (6, 
7), and human have been shown to contain  sero- 
tonin and ATP (8) as well as ADP (14). However, 
generally,  the preparation of dense granules from 
human platelets  has been accompanied by such a 
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14,  20,  27)  that the  evidence  for  the  storage  of 
serotonin,  ATP,  ADP,  and calcium  in  the  same 
granule  fraction  has been either equivocal or in- 
direct as from  selective secretion  studies  or from 
platelets of  patients  with  storage  pool  deficiency 
(12,  18,  19). 
Acting  on  the  premise  that  the  process  of 
homogenization  itself triggers the secretion proc- 
ess in human platelets, we sought to inhibit release 
before  homogenization  and  fractionation.  It  has 
been shown  that the  use  of a  glycolytic inhibitor 
together with a  respiratory blocker inhibits plate- 
let  secretion  (23)  by  depleting the  metabolically 
active  ATP  without  affecting  the  intragranular 
ATP and  ADP  (16).  This approach  has made  it 
possible to prepare a  granule  fraction that is 40- 
60-fold enriched in serotonin from  human plate- 
lets  with  only  about  20%  solubilization  of  the 
amine.  The  ATP and  ADP  in this fraction have 
also  been  estimated  and  compared  with  the  se- 
creted amounts,  which up to now have provided 
the main body of data about the granule contents. 
MATERIALS  AND  METHODS 
Fractionation 
Platelet-rich plasma prepared from  140  ml of blood 
collected into 16 ml of ACD  (1) from healthy donors 
was usually incubated for 15 rain at 37"C with 1 /zM [2- 
14C]serotonin  (5-hydroxytryptamine binoxalate, 48.5 Ci/ 
mol from New England Nuclear Corp., Boston, Mass.). 
Then 0.1  M sodium EDTA, pH 7.4, was added to the 
platelet-rich plasma to make a final concentration of 5 
mM, and the platelets were centrifuged at 3,000 g  x  10 
min at 4~  The platelet pellet was suspended in an ice- 
cold,  modified Tyrode's solution, pH 6.5,  without cal- 
cium  and  with  1  mM  EDTA,  0.1%  bovine  serum 
albumin  (Calbiochem,  San  Diego,  Calif.,  fraction  V) 
and 2 mM MgCI2. After centrifugation at 3,000g  x  10 
min at 4"C, the platelets were resuspended in 15 ml of 
the same medium and incubated with the inhibitors 20 
/zM rotenone (Sigma Chemical Co., St. Louis, Mo.) and 
5 mM 2-deoxyglucose at 37~  for 20 min. Then, 3 mg 
of Nagarse  (Enzyme Development Corp.,  New  York) 
and  10 mg of ATP were  mixed into the suspension at 
room  temperature. 1 5  min  later,  20  mg  of  soybean 
trypsin  inhibitor (Sigma)  was  added  to  neutralize the 
Granule preparations in which  the  nagarse  pretreat- 
ment was omitted could not be resuspended well and did 
not separate on the sucrose gradient to give a pellet. The 
use of ATP with the nagarse was arrived at empirically; 
for some reason ATP seems to prevent platelet clump- 
ing that often occurs with nagarse addition (26). 
nagarse, and after the suspension was stirred well,  the 
platelets were centrifuged at 3,000 g  ￿  10 min at 4~ 
The  platelet pellet was then resuspended in  20  ml  of 
medium  consisting  of  0.25  M  sucrose,  10  mM  Tris 
chloride and 1 mM sodium EDTA, pH 7.4, 0~  (isola- 
tion medium). The platelet suspension was homogenized 
twice  at  1,000  pounds  per  square  inch  in  a  French 
pressure  cell  as  described  previously  (25)  with  one 
centrifugation in between the  two  breaks so that only 
the unbroken ceils were subjected to the second homog- 
enization.  Differential centrifugation of the  combined 
homogenate  resulted  in  the  isolation  of the  following 
fractions: FI,  1,000 g  ￿  22 min pellet (whole platelets 
and  large  fragments);  F~,  12,000  g  ￿  20  rain  pellet 
(mitochondria and granules); F3,  100,000 g  x  60 min 
pellet (membranes); and F4,  the  100,000 g  supernate 
(all soluble material). 
The granule fraction, F~, was resuspended in 2.5  ml 
of  the  sucrose  isolation  medium,  and  1.5  ml  of  this 
suspension was  further fractionated on  a  sucrose  step 
gradient  that  increased  from  0.8  to  2.0  M  in  0.2-M 
increments as described previously (26). 
In some of the experiments, platelets were prelabeled 
for 30 rain at room temperature in platelet-rich plasma 
with 0.2  /~M  [G-all]adenine (6,000 Ci/moi from New 
England Nuclear Corp. [15]); part of the washed platelet 
suspension was  reserved for secretion studies, and the 
rest was fractionated as described above. 
Secretion Studies 
0.2 ml portions of the suspension of washed platelets 
that were not treated with rotenone and 2-deoxyglucose 
were incubated at 37~  for 5  min in the presence and 
absence of 5 U of thrombin. The platelets were removed 
from the  medium  by centrifugation for analysis of the 
secreted  substances  in  the  supernatant  solution  and 
compared to total content. 
Assays 
fl-N-Acetylglucosaminidase,  acid  phosphatase,  and 
a-glycerophosphate oxidase  were  assayed by standard 
methods  (10,  24)  as  described  previously  (26). 
[14C]Serotonin  was  monitored by adding 20-50-/~1  ali- 
quots  of sample  to  15  ml  of a  toluene/Triton  X-100 
(2:1)  cocktail  with  6  g/liter  of  2,5-diphenyloxazole 
(PPO)  and  75  mg/liter of  1,4-bis[2(5-phenyloxazole)] 
(POPOP) for counting in a Nuclear-Chicago liquid scin- 
tillation counter (Nuclear-Chicago  Corp.,  Des  Plaines, 
Ill.). The absolute amounts of serotonin were estimated 
in  a  few  experiments  by  the  butanol  extraction-HC1 
fluorescence method described by Weissbach et al. (30) 
in the platelet homogenate, F2 and in the pellet at the 
bottom of the 2.0 M sucrose gradient and was found to 
be  proportional  to  the  counts  per  minute.  ATP  and 
ADP were assayed by the firefly  method (17) or fiuori- 
metrically (33) in extracts prepared by the addition of 
one portion of sample to two portions 10 mM EDTA in 
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by  following  NADH  oxidation  at  340  nm  after  the 
addition  of  pyruvate.  Proteins  were  determined  by 
Miller's modification (22) of Lowry's method; albumin 
standards were run at each sucrose concentration of the 
gradient. 
Electron Microscopy 
Fractions F1, F2, and F3 and subfractions A-P (from 
the sucrose density gradient) were fixed in 2.5% glutar- 
aldehyde in 0.067  M  cacodylate buffer, pH  7.4,  post- 
fixed  in  1%  osmium  tetroxide  in  the  same  buffer, 
dehydrated  in  ethanol  and  embedded  in  Epon  812. 
Sections were  stained with uranyl-acetate followed  by 
lead citrate. Addition of sucrose to the glutaraldehyde to 
increase the osmolality had no effect on the appearance 
of the samples. 
RESULTS 
Initial attempts at the isolation of human platelet 
dense  granules  were  made  by the  direct applica- 
tion  of  the  method  developed  in  this laboratory 
for  pig  platelet  fractionation  (26).  Unlike  pig 
platelets, human platelets aggregated and released 
more  than  90%  of their serotonin content to the 
extracellular  medium  during  the  centrifugation 
after the nagarse pretreatment.  Addition of tryp- 
sin  inhibitor  after  the  nagarse  pretreatment  re- 
suited  in  occasional  preparations  that  did  not 
aggregate  and release,  but the  yield of serotonin 
in the granule fraction was extremely variable (see 
Table I).  In experiments 1 and 2  (Table I), about 
half  of  the  serotonin  was  found  in  the  soluble 
phase,  but  the  amount  in  the  granules  differed 
sharply.  In experiments 3-6,  the homogenization 
pressure was decreased to 800 pounds per square 
inch to  try  to  reduce  serotonin release,  with the 
result that fewer platelets were  disrupted than at 
1,000  pounds  per  square  inch,  and  the  granule 
yields remained low. 
At  this  point,  it  was  decided  to  try  metabolic 
inhibitors in  combination  with  a  homogenization 
pressure  of  1,000  pounds  per  square  inch  to 
determine  whether the  high degree  of serotonin 
solubilization was due to secretion or to organelle 
damage.  The  optimal conditions for inhibition of 
platelet secretion were first established by incubat- 
ing platelets with rotenone, a  mitochondriai inhib- 
itor,  and 2-deoxyglucose,  an inhibitor of glycoly- 
sis;  at  various  times,  thrombin  was  added  to 
aliquots of platelet suspension to induce secretion. 
Table II shows that thrombin-induced secretion in 
washed platelets was maximally inhibited by rote- 
none and 2-deoxyglucose in about 15 min. 
Platelets  pretreated  with inhibitors for  20  min 
as described  in Table II before the nagarse treat- 
ment did not aggregate  or release  upon centrifu- 
gation. In addition, some 30% of the total platelet 
serotonin was found in the crude granule fraction 
(F2) after homogenization  (Table I).  Attempts to 
improve this yield by increasing the homogeniza- 
tion pressure  and rupturing more  of the platelets 
that appeared in the low-speed pellet (F  0  resulted 
only in greater serotonin solubilization. Although 
the  membrane  fraction  (Fa)  was  not  separated 
TABLE  I 
Effect of Metabolic lnhibitors on [14C]Serotonin Distribution in Primary Fractions 
Fa + ( (Membranes + Cyto- 
Exp no.  F~ (CeUs & Debris)  Fz (Granules)  sol) 
No Inhibitors 
%  %  % 
1  12.4  23.9  63.7 
2  21.9  5.2  46.8 
3  55.0  11.4  21.8 
4  68.8  11.2  20.0 
5  70.2  4.6  25.1 
6  72.4  7.8  19.7 
Rotenone  31.4  34.9  32.7 
2-Deoxyglucose  -+ 1.83  •  2.10  --+ 2.44 
Mean (n =  9) 
•  SEM 
Platelets were homogenized as described in Materials and Methods with or without preincubation with rotenone 20 
/~M and 2-deoxyglucose 5 mM at 37~  for 20 min. The first two experiments without inhibitors were carried out at 
homogenization pressures of 1,000 pounds per square inch and the next four at 800 pounds per square inch. The 
nine experiments with inhibitors were carried out at 1,000 pounds per square inch. 
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Inhibition of [~4C]Serotonin Secretion by Rotenone and 2-Deoxyglucose 
Incubation time (rno~)before 
t hrombin addition  0  5  10  20  30 
%  %  %  %  % 
Control  59.0  61.23  60.20  64.15  48.00 
SEM  -- 7.86  -- 8.26  +_ 7.78  • 8.02  -+ 8.62 
Rotenone  +  2-deoxy- 
glucose  19.68  12.03  6.08  5.08  2.93 
SEM  -+ 9.12  -  6.54  -+ 3.08  --- 1.98  --- 0.62 
Rotenone 20  ~M and 2-deoxyglucose  5 mM (final concentrations) were added to one of two identical  portions of 
platelet suspensions (about 1.5-2.0 mg of protein/ml) that had been preincubated at 37~  for 10 min. Aiiquots of 
0.5 ml were taken from the suspension to which the inhibitors were added as well as from the control suspension at 
the times noted and challenged with 0.5  unit of thrombin. The aliquots  were centrifuged after 10 rain at 37~  and 
the amounts of [14C]serotonin present in the supernates were compared to those in the whole suspension. The results 
are presented as means -  SEM (n  = 4). 
TABLE III 
Distribution of [14C]Serotonin 
F~  F2  F~  F~  Fz+~ 
n  9  9  5  5  4 
% of ~1  homogenate 
Mean  31.44  34.89  9.84  20.60  32.66 
SEM  1.83  2.10  1.49  2.66  2.44 
A  B  C  D  E  F  E+F  P 
n  9  9  9  9  7  7  2  9 
% ofF2 on sucrose density gradient 
Mean  11.89  3.22  4.56  5.56  5.14  8.43  11,50  61.44 
SEM  0.92  0.28  0.63  0.44  0.83  1.11  2.50  1.49 
The mean  -  S.EM. is given for the percent of [14C]serotonin recovered in each fraction  and subfraction in nine 
preparations. In four fractionations, F.~ and F4 were not separated, and in two preparations, subfractions E and F 
were not collected separately. 
from the soluble fraction (F4) in these preliminary 
studies, this separation was carried out after the 
optimal fractionation conditions were established, 
and only  20%  of the  serotonin was found to be 
solubilized (see Table III). 
Table  IV  shows  the  distribution  of  [14C]sero- 
tonin,  acid  phosphatase,  /3-N-acetylglucosamini- 
dase and  a-glycerophosphate oxidase in a  typical 
fractionation. Fraction 2  contained the most pro- 
tein  of  the  particulate  fractions,  the  largest 
amounts of the assayed components and less than 
1%  of  the  lactate  dehydrogenase  (not  shown). 
The  specific activities of the  marker  enzymes in 
Table  IV also peaked in fraction 2,  although the 
concentration of serotonin in  cpm/mg of protein 
was greater in fraction 1 which consisted of whole 
platelets  and  large  fragments/  Electron  micro- 
graphs showed fraction  2  to  consist primarily of 
platelet  mitochondria,  granules,  and  membrane 
vesicles (Fig. 1 a). 
Fraction 2  was centrifuged on the sucrose den- 
sity gradient described in Materials and Methods, 
and five bands of material plus a small pellet were 
visible (Fig.  2).  Seven subfractions, A-F  and  P, 
were collected as indicated, and the assayed com- 
ponents were found to be distributed as shown in 
2 The distribution of particle  size as determined with a 
Coulter  Counter  ZBI  in  washed platelets showed the 
same profile as fraction 1 and indicated that the homog- 
enization procedure  was  not  selective  with  respect to 
platelet size. 
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Distribution of Marker Components in Primary Fractions 
No. 98-817  ~N-acetyl-glucosa-  a-Glycerophosphate  oxi- 
Fraction  Protein  Serotonin  Acid phosphatase*  minidase*  dase:~ 
mg/ral  cpm ￿  l O-a/mg  nmol/min/mg  nmollmin/mg  natomslminlmg 
Homogenate  1.89  11.17  64.92  13.72  40.74 
F~  0.86  28.82  82.09  22.40  89.53 
(11.6%)  (37.2%)  (15.7%)  (22.1%)  (31.0%) 
F~  2.25  24.66  135.38  42.20  146.7 
(15.2%)  (41.5%)  (33.9%)  (54.5%)  (66.4%) 
F3  0.61  4.30  128.03  23.00  10.8 
(8.2%)  (4.2%)  (17.4%)  (16.1%)  (2.7%) 
F4  0.32  2.39  29.75  1.12  Not 
(64.9%)  (17.2%)  (33.0%)  (7.3%)  measurable 
Total recovery  88.9%  71.9%  83.1%  76.3%  73.4% 
Activities are expressed as cpm, p-nitrophenol* production or oxygen:~  consumption per milligram of protein. The 
percentage of the total recovered activity found in each fraction is given in parentheses. All enzymes were assayed in 
the presence of 0.5% Triton X-100. 
Table V and Fig. 2. Acid phosphatase activity was 
highest in the upper part of the sucrose gradient, 
A  and  B.  /3-N-Acetylglucosaminidase  activity 
peaked  in  B  and  C,  although  a  small  amount 
(2.9%)  peaked in the  pellet. The  mitochondrial 
marker enzyme, a-glycerophosphate oxidase, was 
concentrated  10-fold over  the  original homoge- 
hate in subfraction B. Serotonin, which was found 
mostly in the pellet, was enriched 49 times com- 
pared to the homogenate. The actual amount of 
serotonin  in  the  pellet  was  92.2  nmol/mg  of 
protein.  Since  the  [14C]serotonin  incorporation 
into platelets varied somewhat from preparation 
to preparation, the cpm/mg of protein could not 
be compared advantageously, but the normalized 
distribution of labeled serotonin in nine fractiona- 
tions was very reproducible and is shown in Table 
lII. 
Electron micrographs showed that  subfraction 
A  consisted  primarily of  membrane  and  mem- 
brane  vesicles,  which  was  consistent  with  acid 
phosphatase  activity, and some  entrapped gran- 
ules (not shown). Subfraction B  was greatly en- 
riched  in mitochondria (Fig.  lb ),  which  agrees 
with the localization of the mitochondrial marker 
enzyme,  ot-glycerophosphate  oxidase  (Table  V, 
Fig.  2).  Subfractions  D  and  E  consisted  of  a- 
granules that appeared to be ultrastructurally ho- 
mogeneous (Fig.  3a);  these  fractions appear  to 
contain more protein than would be accounted for 
by the enzyme markers used in this study and are 
probably enriched in some of the  other proteins 
known to be secreted by platelets. Subfraction P, 
in which the  greatest  concentration of serotonin 
was  found, contained several forms of granules 
(Fig. 3 b ). One type was the typical bull's eye, and 
the others were more completely filled and varied 
in shape from round to elongated. 
Determination of the subcellular localization of 
the storage or secretable ATP and ADP is compli- 
cated by the presence of the metabolically active 
adenine nucleotides of the  cell that  are  not se- 
creted (1). These two pools can be distinguished 
by the fact that the  metabolically active adenine 
nucleotides can be labeled in vitro by preincuba- 
tion of an appropriate precursor such as  [aH]- or 
[14C]adenine with platelets in plasma; under these 
conditions, the stored nucleotides are not labeled 
(15). Therefore, a  series of fractionation experi- 
ments were performed with platelets in which the 
metabolically active adenine nucleotides were pre- 
labeled  with  radioactive  adenine  instead  of 
[t4C]serotonin. 
The  amounts and the  specific  radioactivity of 
the ATP and ADP in various fractions of platelets 
prelabeled with  [3H]adenine are  shown in Table 
VI. The ratio of ATP and ADP in whole platelets 
was 1.64, and the specific radioactivity of the ATP 
+  ADP was  866  cpm/nmol. When the  platelets 
were  treated  with  thrombin with  thrombin and 
centrifuged out  of the  medium, the  supernatant 
solution contained about 55 % of the platelet ATP 
and ADP in a ratio of 0.68. Most of the ADP in 
the  platelets  was  secreted,  so  that  the  ratio  of 
nonsecretable  ATP  to  ADP  (the  metabolically 
active pool) in the resting platelet was 9.63. The 
FUrAMI ET  AL.  Isolation of Dense Storage Granules from Human Platelets  393 FIGURE  1  (a)  Fraction  2  from differential centrifugation.  Membrane fragments, a-granules, mitochon- 
dria,  and dense granules, including bull's eyes, were all present in  this fraction.  Bar,  1  /zm.  x  20,500. 
(b)  Subfraction  B  from  sucrose  density  gradient.  This band  consisted mostly of mitochondria  in  the 
condensed form with a  little contamination from  a-granules. Bar, 0.5  /zm.  x  41,600, 
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FIGURE  2  Relative specific activities of marker components in sucrose density gradient subfractions. A 
diagram of the  sucrose  density gradient and  the  subfractions into which it was divided is shown (top 
center). The relative specific activities of the components were calculated as the quotient of the specific 
activity in a subfraction divided by the specific activity of the homogenate as given in Tables I and II. 
TABLE W 
Distribution of Marker Components in Subfractions of Fraction 2 
No. 98-817  fl-N-acetylglucosamin- a,-Glycerophosphate  oxi- 
Fraction  Protein  Serotonin  Acid phosphatase  idase  dase 
mg/ml  cpm x 10 a/mg  nmol/min/mg  nmol/min/mg  natoms/rain/rng 
F~  2.25  24.66  135.38  42.20  146.7 
A  0.22  17.52  134.78  28.30  49.1 
(27.3%)  (15.4%)  (43.8%)  (20.3%)  (11.4%) 
B  0.39  7.50  144.94  58.41  488.5 
(15.5%)  (3.7%)  (26.8%)  (23.8%)  (64.6%) 
C  0.40  8.61  78.48  68.45  137.5 
(11.3%)  (3.1%)  (10.6%)  (20.4%)  (13.3%) 
D  0.56  7.98  59.93  40.95  59.2 
(15.8%)  (4.1%)  (11.3%)  (17.0%)  (8.0%) 
E  0.41  9.21  18.68  34.02  26.8 
(11.6%)  (3.4%)  (2.6%)  (10.4%)  (2.7%) 
F  0.21  26.90  24.62  11.83  Not 
(15.3%)  (13.3%)  (4.5%)  (5.1%)  measurable 
P  0.11  548.50  12.98  34.39  Not 
(3.2%)  (57.0%)  (0.5%)  (2.9%)  measurable 
Total  recov-  104.6%  131.8%  64.9%  94.2%  83.6% 
ery 
Activities and recoveries are expressed as in Table I. 
395 FmURE  3  (a) Subfraction D from sucrose density gradient. This band consisted of a-granules with very 
little contamination with other organelles or membranes. The granules were round, elongated, or racket 
shaped. Bar, 0.5  /zm.  ￿  32,500.  (b)  Pellet (Subfraction P) from sucrose density gradient. This fraction 
was greatly enriched in dense granules of the bull's-eye type compared to the starting material, Fig.  1 a. 
However,  there  were  also  a  few  membrane  fragments and  numerous  other  granules  (see  Discussion 
section about their possible identity). Bar, 1 /xm. ￿  25,000. TABLE VI 
Localization of Storage Pool A TP and A D P 
ATP 
ATP  ADP  ADP  ATP +  ADP 
Whole platelets 
Platelet  supernate  after 
thrombin* 
Whole  platelets  minus 
platelet supernate after 
thrombin 
Crude  granule  fraction 
(F2) 
Dense granules (P) 
nmol/mg of  protein  nmol/mg of  protein  cpm/nmol 
23.8  --_  3.45  14.5  •  2.37  1.64  866 
9.71  -  1.31  14.1  •  1.76  0.68  40 
14.17 •  3.01  1.47 ~  0.47  9.63  2,236 
16.15 _  5.42  26.69 •  7.09  0.60  174 
441  -  95.9  633  --_ 142  0.70  28 
Secretion experiments were performed on aliquots that were reserved before treatment of platelets with rotenone 
and 2-deoxyglucose  for homogenization. The secreted ATP and ADP which appeared in the platelet supernate after 
5 units of thrombin was added had a low specific radioactivity as did the dense granule material. The ATP and ADP 
concentrations are given as the means •  n  =  5. The ATP/ADP ratios are derived from the means. The 
specific radioactivities are the average of two determinations. (ATP and ADP were separated by high voltage paper 
electrophoresis [16].) 
* The concentrations of ATP and ADP in the platelet supernate are expressed in terms of whole platelet protein 
rather than secreted protein. 
secreted ATP and ADP did not exchange rapidly 
with the labeled pool and had a specific radioactiv- 
ity of 40 cpm/nmol compared to 2,236 cpm/nmol 
for the metabolically active pool. Fraction 2, the 
granule preparation obtained by differential cen- 
trifugation, appeared  to  contain  mostly  storage 
nucleotides, from the similarities of the ATP/ADP 
ratio of 0.60 and specific radioactivity of 174 cpm/ 
nmol compared to those of the secreted material. 
The ATP and ADP in subfraction P from sucrose 
density gradient fractionation were about 40 times 
more concentrated per milligram of protein than 
the  secreted  material  per  milligram of  platelet 
protein; the ATP to ADP ratio and specific radio- 
activity were similar to those of the secreted ATP 
and ADP. The recovery of ATP and ADP in the 
dense granule pellet in five experiments was  35- 
49%  of that measured in fraction 2 which aver- 
aged 16% of the total platelet ATP and ADP. 
DISCUSSION 
Results  from  secretion  (13)  and  ultrastructural 
studies  (21,  29)  have  suggested that  the  dense 
granules in  human platelets  contain serotonin, 
ATP, ADP, and calcium. However, isolation of 
these  granules from  human platelets  has  been 
difficult since a  large percentage of the granule 
constituents was  released  to  the  soluble  phase 
during fractionation in most previous studies (3, 
5, 8, 10, 11, 14, 20, 27). One notable exception 
is  the  report  by  Buckingham  and  Maynert  in 
which only 20% of the serotonin appeared in the 
supernate, but  other granule constituents were 
not measured (4). DaPrada et ai. isolated gran- 
ules that were greatly enriched in serotonin and 
ATP from several animal species (6, 7) and from 
human platelets (5, 8), but the yield of serotonin 
granules  in  the  latter  preparations  was  appar- 
ently rather poor (5). Holmsen et al. described a 
fraction obtained from human platelets that was 
several-fold  enriched  in  serotonin,  ATP  and 
ADP,  but  over  90%  of  these  substances  was 
found in the soluble fractions (14). Dense bodies 
from  human platelets isolated  by Broekman et 
al.  were  only  three-  to  fourfold  enriched  in 
serotonin, and much of it was solubilized (3). 
In our preparation of human platelet storage 
granules, the serotonin was 40-60 times enriched 
compared to the platelet homogenate, and only 
20% was in the soluble phase after homogeniza- 
tion.  We attribute the  minimization of solubili- 
zation to the use of inhibitors of energy metabo- 
lism to block platelet secretion (23) induced by 
homogenization. Aspirin was used in our initial 
studies, but solubilization  occurred in about 50% 
of the  preparations.  The  combination of mito- 
chondrial  and  glycolytic  inhibitors,  which  is 
known to deplete metabolic ATP without affect- 
ing the stored ATP and ADP (16), was effective 
in blocking secretion (Table II). In addition, it 
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besides being a respiratory inhibitor, also inhibits 
microtubule assembly (2) in a manner similar to 
colchicine which  has  been  reported  to  dissolve 
platelet  microtubules  and  results  in  loss  of the 
platelet's  ability  to  maintain  a  discoid  form  in 
plasma (31); this effect of rotenone on microtu- 
bules may also contribute to our final results. 
The recovery of ATP and  ADP in the storage 
granules  compared  to  intact  platelets  is  more 
difficult  to  evaluate  than  that  of  serotonin  be- 
cause  the  metabolically  active  portion  of  the 
platelet ATP and ADP is not secreted. Further- 
more,  when  platelets  undergo  secretion  or  are 
treated with inhibitors of energy metabolism, the 
metabolically  active  ATP  is  degraded  rapidly 
through  the  sequence  ADP,  AMP,  IMP,  to 
inosine  and  hypoxanthine  (13).  Therefore,  cal- 
culations  of the  metabolically active pool  must 
be made by subtraction of the secreted materials 
from the total contents of platelets in the resting 
state  as  in Table IV. If one considers that all of 
the serotonin and about half of the platelet ATP 
and  ADP  is  stored  in  subfraction  P,  a  yield of 
ATP and ADP of 10%  would be comparable to 
a  recovery  of  20%  for  serotonin.  We  found 
somewhat less, about 8%, and there are several 
possible  explanations  for  this.  The  possibility 
that  the  isolated  granules  were  accumulating 
solubilized serotonin was checked by adding la- 
beled  serotonin  to  a  platelet  homogenate  from 
which  all  intact  platelets  had  been  removed. 
After fractionation,  about  5%  of the  label  was 
found  to  be  incorporated  into  subfraction  P  at 
the  bottom of the  sucrose  gradient,  which indi- 
cated  that  the  dense  granules  were  indeed able 
to accumulate some serotonin after removal from 
the  intact  platelet.  A  second  possibility  is  that 
some solubilization of granule contents can occur 
with normal handling  (centrifugation and  resus- 
pension),  and that solubilization may be greater 
for some compounds than others, depending on 
their  storage  mechanisms,  which  are  unknown. 
A third and more unlikely possibility is that some 
of the nonmetabolic ATP and ADP is located in 
other compartments. 
Electron  micrographs  of  subfraction  P  show 
that the dense bodies are not uniform in appear- 
ance.  Da  Prada  et  al.  also  isolated  a  human 
platelet  dense  granule  fraction  (5)  which  was 
more  heterogeneous  in  appearance  than  rabbit 
dense  granules  which seemed  to  consist  mainly 
of the bull's eye type  (7).  However, it has been 
suggested  by  other workers that  serotonin  stor- 
age  organelles in human  platelets are heteroge- 
neous  in  appearance.  White  has  characterized 
dense  bodies  in  human  platelets  as  being  of 
several types, bull's eye as well as  signet ring in 
shape,  with  some  that  fill  the  enclosing  mem- 
brane completely while others have long shaftlike 
tails (32).  Skaer et  al.  have also observed these 
different  shapes  of  dense  bodies  in  situ;  they 
found  that  the  P:Ca  atomic ratio  was  the  same 
for the various shapes (29). 
Preliminary work  indicated that  high concen- 
trations of calcium are also present in these dense 
granules, and  the atomic ratio of P:Ca as calcu- 
lated from the ATP and ADP content was com- 
parable to the value of 1.76 which was found by 
electron microprobe analysis (29). 
Serotonin  storage  granules  have  previously 
been  isolated  from  the  platelets  of guinea  pig, 
rabbit,  and  pig  (6,  7,  26)  without  resorting  to 
extraordinary  procedures,  but  human  platelet 
dense  bodies  have  always  seemed  to  be  more 
labile and their contents more easily solubilized. 
Our fractionation results with human platelets in 
which  secretion  was  inhibited  indicate  that  the 
granules per se are not more fragile than those in 
platelets  of other  species,  but  that  secretion  is 
easily  induced  in  human  platelets  by  the  usual 
homogenization  procedures,  with  the  possible 
exception of ultrasonication (4). 
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